These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 17437768)
1. Prostate cancer--more information and more questions. Dall'Era M; Carroll PR J Urol; 2007 May; 177(5):1607-8. PubMed ID: 17437768 [No Abstract] [Full Text] [Related]
2. PSA and prostate cancer screening: the challenge of the new millennium. Bjartell A Eur Urol; 2007 Nov; 52(5):1284-6. PubMed ID: 17720305 [No Abstract] [Full Text] [Related]
3. Risk of prostate cancer for young men with a prostate specific antigen less than their age specific median. Loeb S; Nadler RB; Roehl KA; Antenor JA; Catalona WJ J Urol; 2007 May; 177(5):1745-8. PubMed ID: 17437803 [TBL] [Abstract][Full Text] [Related]
4. Early diagnosis of prostate cancer: the continuing debate on the impact on mortality. Höltl W; Lunglmayr G Wien Klin Wochenschr; 2005 Jul; 117(13-14):440-1. PubMed ID: 16091868 [No Abstract] [Full Text] [Related]
6. Re: Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005. Belpomme D; Irigaray P J Natl Cancer Inst; 2010 Apr; 102(7):506-7. PubMed ID: 20190186 [No Abstract] [Full Text] [Related]
7. Screening for prostate cancer - will we ever know? Adolfsson J Acta Oncol; 2010 Apr; 49(3):275-7. PubMed ID: 20397764 [No Abstract] [Full Text] [Related]
9. Application of prostate-specific antigen in prostate cancer. Liang SL MLO Med Lab Obs; 2008 Oct; 40(10):54, 56-7. PubMed ID: 18988558 [No Abstract] [Full Text] [Related]
10. PSA screening: the bottom line. Elhilali MM CMAJ; 2000 Mar; 162(6):791-2. PubMed ID: 10750466 [No Abstract] [Full Text] [Related]
11. Mass screening for prostate cancer. The Swedish Council on Technology Assessment in Health Care. Int J Cancer Suppl; 1996; 9():1-72. PubMed ID: 8982323 [No Abstract] [Full Text] [Related]
12. [The prostate specific antigen: what can we learn from the American experience?]. Zhao XJ Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3313-5. PubMed ID: 16409833 [No Abstract] [Full Text] [Related]
14. Prostate cancer: is the PSA test the answer? Berlin B N J Med; 1998 Mar; 95(3):53-5. PubMed ID: 16013148 [No Abstract] [Full Text] [Related]
15. Solving the overdiagnosis dilemma. Esserman L; Thompson I J Natl Cancer Inst; 2010 May; 102(9):582-3. PubMed ID: 20413743 [No Abstract] [Full Text] [Related]
16. [PSA based screening for prostatic cancer]. Johansen TE Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2612-4. PubMed ID: 19023357 [No Abstract] [Full Text] [Related]
17. Prostate cancer--the snowball is rolling. Ruutu M; Salo J; Nordling S; Rannikko S Ann Chir Gynaecol; 1999; 88(1):5-8. PubMed ID: 10230675 [No Abstract] [Full Text] [Related]
18. [Prostate-specific antigen--the most important cancer marker. Diagnostics and follow up of prostatic cancer have changed]. Bratt O; Björk T Lakartidningen; 2007 Nov 14-20; 104(46):3460-4. PubMed ID: 18072615 [No Abstract] [Full Text] [Related]
19. Re: Prostate-specific antigen: a misused and maligned prostate cancer biomarker. Hamilton RJ; Platz EA; Freedland SJ J Natl Cancer Inst; 2009 Apr; 101(8):611-2. PubMed ID: 19351913 [No Abstract] [Full Text] [Related]
20. Screening for prostate cancer in 2007: the PSA era and its challenges are not over. Shariat SF; Karakiewicz PI Eur Urol; 2008 Mar; 53(3):457-60. PubMed ID: 18079050 [No Abstract] [Full Text] [Related] [Next] [New Search]